Chemoinformaics analysis of DODECYL PROP-2-ENOATE
| Molecular Weight | 240.387 | nRot | 12 |
| Heavy Atom Molecular Weight | 212.163 | nRig | 21 |
| Exact Molecular Weight | 240.209 | nRing | 0 |
| Solubility: LogS | -4.2 | nHRing | 0 |
| Solubility: LogP | 6.091 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 45 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 45.3242 |
| nHD | 0 | BPOL | 30.6938 |
| QED | 0.258 |
| Synth | 5.399 |
| Natural Product Likeliness | 2.21 |
| NR-PPAR-gamma | 0.971 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.058 |
| Pgp-sub | 0.013 |
| HIA | 0.083 |
| CACO-2 | -5.239 |
| MDCK | 0.0000218 |
| BBB | 0.024 |
| PPB | 0.962653 |
| VDSS | 1.026 |
| FU | 0.0214149 |
| CYP1A2-inh | 0.007 |
| CYP1A2-sub | 0.199 |
| CYP2c19-inh | 0.022 |
| CYP2c19-sub | 0.923 |
| CYP2c9-inh | 0.092 |
| CYP2c9-sub | 0.804 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.07 |
| CYP3a4-inh | 0.64 |
| CYP3a4-sub | 0.75 |
| CL | 11.297 |
| T12 | 0.02 |
| hERG | 0.001 |
| Ames | 0.002 |
| ROA | 0.875 |
| SkinSen | 0.047 |
| Carcinogencity | 0.087 |
| EI | 0.043 |
| Respiratory | 0.98 |
| NR-Aromatase | 0.778 |
| Antiviral | Yes |
| Prediction | 0.782816 |